These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. SOME ASPECTS OF THE ABSORPTION AND EXCRETION OF N-METHYLOL-CHLORTETRACYCLINE. TUBARO E Arzneimittelforschung; 1964 Dec; 14():1355-9. PubMed ID: 14341626 [No Abstract] [Full Text] [Related]
24. [Study of direct fluorophotometric and flow-injection fluorophotometric methods based on the inhibitory effect for the determination of trace formaldehyde]. Ouyang XQ; Xie ZH; Guo ZF; Lin XC; Guo LQ Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Nov; 24(11):1395-9. PubMed ID: 15762486 [TBL] [Abstract][Full Text] [Related]
25. Effect of aureomycin on the clotting time of the blood. SHAPSE JB; WRIGHT LT Angiology; 1950 Aug; 1(4):306-11. PubMed ID: 15432961 [No Abstract] [Full Text] [Related]
26. [Axial and para-axial fluorophotometry in optic neuropathies]. Szymański A; Gierek-Lapińska A; Koziak M Klin Oczna; 1996 Jan; 98(1):5-8. PubMed ID: 9019576 [TBL] [Abstract][Full Text] [Related]
27. The influence of aureomycin on human coagulability. LASSER RP; VERSAKOS M; LOEWE L Angiology; 1950 Jun; 1(3):233-5. PubMed ID: 15425859 [No Abstract] [Full Text] [Related]
28. Serum levels of aureomycin in foals. McCOLLUM WH; DOLL ER Vet Med; 1951 Mar; 46(3):84-6. PubMed ID: 14817952 [No Abstract] [Full Text] [Related]
30. The effect of antacid preparations on serum aureomycin levels. WILLIAMS ML; WEEKES DJ Rev Gastroenterol; 1951 Feb; 18(2):128-30. PubMed ID: 14816635 [No Abstract] [Full Text] [Related]
31. Antibiotic activity in urine and feces after oral and intravenous administration of demethylchlortetracycline. Sweeney WM; Dornbush AC; Hardy SM N Engl J Med; 1960 Sep; 263():620-4. PubMed ID: 13836078 [No Abstract] [Full Text] [Related]
32. Intravenous administration of aureomycin including studies on the concentration in the serum. RANDALL RV; TAYLOR RW; WELLMAN WE Proc Staff Meet Mayo Clin; 1949 Dec; 24(25):605-11. PubMed ID: 15399063 [No Abstract] [Full Text] [Related]
33. [Increase of cholesterinemic rate during penicillin and aureomycin therapy]. POLI M Boll Soc Ital Biol Sper; 1950; 26(11-12):1501. PubMed ID: 14839076 [No Abstract] [Full Text] [Related]
34. [Fluorophotometry of changes of hemato-ocular barriers in intermediate uveitis]. Baglivo E; Bloch-Michel E; Ducot B; Offret M; Offret H J Fr Ophtalmol; 1995; 18(6-7):421-5. PubMed ID: 7560782 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of human brucellosis with aureomycin and the association of aureomycin and di-hydrostreptomycin]. GIUNCHI G Clin Nuova Rass Prog Med Int; 1950 Feb; 10(7):264-71. PubMed ID: 15427236 [No Abstract] [Full Text] [Related]
36. [Direct fluorophotometric and flow-injection fluorophotometric methods for the determination of trace ammonia]. Guo LQ; Xie ZH; Lin XC; Ke ZH; Chen GN Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Jul; 24(7):851-4. PubMed ID: 15766089 [TBL] [Abstract][Full Text] [Related]
37. The effect of aureomycin on venous clotting time. BLODGETT WA; SCHILLING FJ Am J Med Sci; 1951 Jun; 221(6):688-90. PubMed ID: 14829472 [No Abstract] [Full Text] [Related]
38. The clinical use of aureomycin. SCHOENBACH EB Med Ann Dist Columbia; 1949 Jun; 18(6):290-3. PubMed ID: 18129924 [No Abstract] [Full Text] [Related]
39. Effect of aureomycin on heparin concentration and clotting time of human blood. WAISBREN BA; GLICK D J Lab Clin Med; 1950 Dec; 36(6):1001. PubMed ID: 14795098 [No Abstract] [Full Text] [Related]
40. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy]. Bordat B; Guirgis IR; Manderscheid JC J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]